News from the AI & ML world

DeeperML

Synced@Synced // 5d
DeepMind has announced significant advancements in AI modeling and biomedicine, pushing the boundaries of what's possible with artificial intelligence. The company's research is focused on creating more effective drugs and medicine, as well as understanding and protecting species around the world.

DeepMind's JetFormer, a novel Transformer model, is designed to directly model raw data, eliminating the need for pre-trained components. JetFormer can understand and generate both text and images seamlessly. This model leverages normalizing flows to encode images into a latent representation, enhancing the focus on essential high-level information through progressive Gaussian noise augmentation. JetFormer has demonstrated competitive performance in image generation and web-scale multimodal generation tasks.

Additionally, DeepMind is exploring how studying honeybee immunity could offer insights into protecting various species. The company's AlphaFold continues to revolutionize biology, aiding in the design of more effective drugs. AlphaFold, which uses AI to determine a protein's structure, has been used to solve fundamental questions in biology, awarded the Nobel prize (in chemistry – to Demis Hassabis and John Jumper) and revolutionised drug discovery. There are approximately 250,000,000 protein structures in the AlphaFold database, which has been used by almost 2 million people from 190 countries.

Share: bluesky twitterx--v2 facebook--v1 threads


References :
  • Synced: DeepMind’s JetFormer: Unified Multimodal Models Without Modelling Constraints
  • www.theguardian.com: AI may help us cure countless diseases – and usher in a new golden age of medicine | Samuel Hume
Classification:
  • HashTags: #DeepMind #JetFormer #AlphaFold
  • Company: Google DeepMind
  • Target: AI researchers
  • Product: AlphaFold, JetFormer
  • Feature: Multimodal models, Drug discov
  • Type: AI
  • Severity: Informative